BCAA catabolic defect is observed in numerous metabolic diseases, including obesity, diabetes, cardiac diseases, and atherosclerosis, and evidence has shown that BCAA catabolic defect plays a causal role in the development of these diseases [16,19,20]. This evidence concerns the gene ARID4B and atherosclerosis.